Welcome to UpcomingEvents.com!! We hope to see you at an event SOON!
Search

Select Region

Featured Regions

Philadelphia, PA Baltimore, MD Atlantic City, NJ

Not what you're looking for? See All Cities

Or

Search by Zip

advertise here
× Your location has been changed to Minneapolis area.
  • Home
  • Events
  • 40th Annual New Treatments in Chronic Liver Disease - CME - San Diego

    • This Event has Passed

    Large

    40th Annual New Treatments in Chronic Liver Disease - CME - San Diego

    Saturday, March 14, 2026 - 7:00 AM
    to Sunday, March 15, 2026 - 12:00 PM

    7:00 AM - 12:00 PM See all dates and Times

    The Seabird Ocean Resort & Spa, a Destination by Hyatt Hotel

    Parking Deals

    Add to Calendar

    03/14/2026 07:00 AM 03/15/2026 12:00 PM America/Boise 40th Annual New Treatments in Chronic Liver Disease - CME - San Diego New Treatments in Chronic Liver Disease will highlight the latest advancements in medications and therapies for liver care and transplantation. The program will offer an in-depth review of clinical trials and real-world data on oral treatments for chronic viral hepatitis B and C, non-alcoholic fatty liver disease, primary biliary cholangitis, primary sclerosing cholangitis, hepatocellular carcinoma, and complications of end-stage liver disease, including thrombocytopenia. This annual CME conference delivers a comprehensive yet targeted program designed to provide physicians with the latest updates and practical insights for managing liver diseases.Event LinksTickets: https://go.evvnt.com/3303... Details & Tickets: https://www.upcomingevents.com/murrieta/events/the-seabird-ocean-resort-spa-a-destination-by-hyatt-hotel/40th-annual-new-treatments-in-chronic-liver-disease-cme-san-diego-544187?ref=uceaddevent The Seabird Ocean Resort & Spa, a Destination by Hyatt Hotel, 101 Mission Avenue, Oceanside, CA, 92054

    Categories

    Continued Learning, Educational, Health & Wellness, Science, Technology

    New Treatments in Chronic Liver Disease will highlight the latest advancements in medications and therapies for liver care and transplantation. The program will offer an in-depth review of clinical trials and real-world data on oral treatments for chronic viral hepatitis B and C, non-alcoholic fatty liver disease, primary biliary cholangitis, primary sclerosing cholangitis, hepatocellular carcinoma, and complications of end-stage liver disease, including thrombocytopenia. This annual CME conference delivers a comprehensive yet targeted program designed to provide physicians with the latest updates and practical insights for managing liver diseases.

    Event Links

    Tickets: https://go.evvnt.com/3303797-0

    Read More

    View Less

    Top